Fabrication and characterization of solid lipid nano-formulation of astraxanthin against DMBA-induced breast cancer via Nrf-2-Keap1 and NF-kB and mTOR/Maf-1/PTEN pathway
In the current experimental study, we scrutinized the chemoprotective effect of astraxanthin against the 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer via Nrf-2-Keap1 and NF-kB and mTOR/Maf-1/PTEN pathway. The double emulsion solvent displacement method was used for the preparation of...
Main Authors: | Tao Sun, Jun Gao, Dan Han, Hongyan Shi, Xianqiang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2019.1667454 |
Similar Items
-
An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia
by: Diana S. Gesto, et al.
Published: (2020-08-01) -
Effects of thymoquinone rich fraction and thymoquinone on plasma lipoprotein levels and hepatic low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes expression
by: Ghanya Al-Naqeep, et al.
Published: (2009-07-01) -
CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
by: Yanbo Wang, et al.
Published: (2021-05-01) -
The KEAP1–NRF2 System in Cancer
by: Keiko Taguchi, et al.
Published: (2017-05-01) -
Glutaredoxin-1 regulates the Keap1-Nrf2 pathway
by: Kim, Maya Hwewon
Published: (2018)